The Institute of Medicine (IOM) recently held a workshop on Sharing Clinical Research Data. Following on from this event, the IOM has announced plans to develop a consensus study on strategies for sharing clinical trial data. The IOM is currently organizing a planning activity that will focus on developing an independent study that would provide guidance. A small planning meeting for potential sponsors and key stakeholders will be held in the near future.
The news has been welcomed by a group of pharma companies including AbbVie, AstraZeneca, Serono, GSK, Roche and Novartis.
Discussions at the IOM workshop has moved the conversation around clinical trial data sharing from whether it should occur, to how it can be enabled, which also mirrors the view of the European Medicines Agency. As data holders are beginning to individually generate policies for clinical trial data access, better alignment among stakeholder actions will be necessary to harness the full potential of data sharing.